-
WCG Launches Program to Provide Clinical Research Professionals with Timely Information During the COVID-19 Pandemic
Mar 23, 2020, 15:53 PM by Michael CroftPRINCETON, NJ - Mar 23, 2020 - WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, this week launched "The WCG Insights Program: Supporting best practices in a global pandemicxFull story -
Rho Experts Share Best Practices for Managing Risks in Clinical Trials
Mar 23, 2020, 13:55 PM by Michael CroftDURHAM - Mar 23, 2020 - Rho Experts Share Best Practices for Managing Risks in Clinical TrialsFree webinar offers insight into recent Good Clinical Practice (GCP) revisions on sponsor responsibilities for risk management WHAT: Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will outline and provide tips on the UFull story -
Global Flow Cytometry Market to Register Impressive Growth, Demand Upheld by Cancer and Stem Cell Research, Says Fact.MR
Mar 23, 2020, 10:31 AM by Michael CroftDUBLIN 2, IRELAND - Mar 23, 2020 - Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interactionFull story -
Creative Diagnostics Now Launches New Plant Pathogens Antibodies for Research Use
Mar 23, 2020, 03:44 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Mar 23, 2020 - As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches high-quality plant pathogens antibodies that are suitable for use in ELISA or related immunoassays and can be ordered in bulk quantityFull story -
Adaptive Biotechnologies, Microsoft Launch Immune Response Trial For COVID-19
Mar 20, 2020, 16:25 PM by Michael CroftBio-IT World Brief | Adaptive Biotechnologies and Microsoft today announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19 in a clinical trial to launch in April.Full story -
BioTeam, NVIDIA, Globus, And More Offer Free Tools To Support Coronavirus Research
Mar 20, 2020, 09:35 AM by Michael CroftBio-IT World | Groups across the Bio-IT World community are offering their services and tools for free to teams working on coronavirus diagnostics and treatments. Offerings from BioTeam, Globus, NVIDIA, the Broad Institute, Rescale, Google Cloud, and Microsoft Azure all aim to speed work done on diagnostics and treatment.Full story -
Creative Proteomics Released Choline and Choline Metabolites Analysis Service for Research Use
Mar 19, 2020, 22:52 PM by Michael CroftSHIRLEY, NY - Mar 20, 2020 - March 20, 2020, Creative Proteomics has released choline and choline metabolites analysis service to assist researchers in their biotechnological projectsFull story -
KONZA to Deliver Actionable Patient Information to Participating Provider Organizations with Diameter Health Technology
Mar 19, 2020, 11:26 AM by Michael CroftFARMINGTON, CT, UNITED STATES - Mar 19, 2020 - Diameter Health, developer of the leading platform for clinical data normalization and enhancement, today announced that KONZA, IncFull story -
Matthew Trunnell On Data, Silos, COVID-19, And Advice To Himself 15 Years Ago
Mar 19, 2020, 10:15 AM by Michael CroftFull storyBio-IT World TRENDS FROM THE TRENCHES—Stan Gloss and Matthew Trunnell discuss how their views of data have changed over the past two decades, what technologies provided tipping points, where the next leaps will happen, and what we may have done differently with the benefit of hindsight. And, of course, a little bit about coronavirus.
-
Albumedix Announces CBER FDA Drug Master File Acceptance for Recombumin® Elite and Appointment of Director of Regulatory Affairs
Mar 19, 2020, 09:01 AM by Michael CroftNOTTINGHAM, ENGLAND - Mar 19, 2020 - Albumedix Ltd. (Albumedix), the world leader in recombinant human albumin (rHA), announced today that the Center for Biologics Evaluation and Research (CBER), one of six main centers for the UFull story -
Robust, Powerful Compound Screening Platform Enhanced for Drug Screening Research
Mar 19, 2020, 04:09 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Mar 19, 2020 - The New York-based chemical supplier BOC Sciences, also one of the active players in early drug discovery, recently announces to enhance its one-stop compound screening platform, which is efficient, economical and systematic, aiming to help scientists fulfill their screening needs arising from drug R&D projectsFull story -
ATCC Partners with Global Scientific Community to Respond to the Coronavirus Pandemic
Mar 18, 2020, 13:54 PM by Michael CroftSAN FRANCISCO BAY AREA, CA, US - Mar 18, 2020 - Manassas, VA - March 18, 2020 - ATCC, the world's premier biological materials management and standards organization, today announced it is expanding its support for the UFull story -
CluePoints´ Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations
Mar 18, 2020, 09:40 AM by Michael CroftKING OF PRUSSIA, PA, US - Mar 18, 2020 - CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreakFull story -
COVID-19 DETECTION IN UNDER 20 MINS – ICENI DIAGNOSTICS OFFERS NEW APPROACH
Mar 18, 2020, 07:20 AM by Michael CroftNORWICH, UK, UNITED KINGDOM - Mar 18, 2020 - The emergence of COVID-19 has exposed a frailty in our ability to rapidly detect and screen new infectious diseasesFull story -
Creative Biolabs Announced Arcitumomab for Research Use
Mar 17, 2020, 21:13 PM by Michael CroftSHIRLEY, NY - Mar 18, 2020 - March 18, 2020, Creative Biolabs, as a leading supplier in the recombinant antibody field, announced the arcitumomab for research useFull story -
Kyruus and GYANT Announce Partnership to Facilitate Chat-Based Patient-Provider Matching and Scheduling
Mar 17, 2020, 10:57 AM by Michael CroftBOSTON AND SAN FRANCISCO, MA, UNITED STATES - Mar 17, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and GYANT, the leading artificial intelligence-enabled virtual assistant for healthcare, today announced a new partnership to help health systems enhance consumer access and self-service on their websitesFull story -
BridgeHead and Summit Advance Healthcare Data Archiving
Mar 17, 2020, 08:17 AM by Michael CroftBRAINTREE, MA, UNITED STATES - Mar 17, 2020 - BridgeHead Software, the leader in healthcare data management, today announced a strategic partnership with Summit Healthcare, a leader in healthcare system integration and automationFull story -
Summit Supercomputer Models Coronavirus 'Spike'
Mar 12, 2020, 11:45 AM by Michael CroftFull storyBio-IT World | As scientists across the globe bring their expertise to bear on the coronavirus pandemic, researchers in Tennessee are bringing big compute. Researchers are using Summit, the world’s fastest supercomputer housed at Oak Ridge National Laboratory (ORNL), to identify compounds that may effectively combat the virus. Summit is powered by 9,216 IBM Power9 CPUs and over 27,000 NVIDIA V100 Tensor Core GPUs.
-
Lifebit Announces ISO Certification, Underscores Commitment to Genomic Data Security
Mar 11, 2020, 07:49 AM by Michael CroftLONDON, UNITED KINGDOM - Mar 11, 2020 - Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, announced it has been awarded International Organization for Standardization (ISO) 27001 certification, a widely recognized international standard outlining best practices for information security management systemsFull story -
How Digital Technology Will Transform Every Part of Life Sciences in 2020
Mar 9, 2020, 13:20 PM by Michael CroftFull storyBio-IT World Contributed Commentary | Achieving a single view of the patient has been a key challenge for the life sciences industry, given the inherently siloed nature of organizations in the sector. However, as patient centricity increasingly becomes the crux of all life science organizations, the pace of digitization within the industry has picked up significantly.